Perioperative PD-1 Inhibition Expands Treatment Opportunities for Select Patients With CSCC
As the role of immunotherapies extends to earlier treatment lines in the nonmelanoma skin cancer treatment armamentarium, increased attention to patient characteristics and disease factors is crucial to ensure all patients receive tolerable therapies at …